199 related articles for article (PubMed ID: 20664331)
1. Clinical implications of the BARI 2D and COURAGE trials: overview.
Brooks MM; Boden WE; Frye RL
Coron Artery Dis; 2010 Nov; 21(7):383-5. PubMed ID: 20664331
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.
Holper EM; Addo T
Coron Artery Dis; 2010 Nov; 21(7):397-401. PubMed ID: 20634692
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).
Tamis-Holland JE; Lu J; Korytkowski M; Magee M; Rogers WJ; Lopes N; Mighton L; Jacobs AK;
J Am Coll Cardiol; 2013 Apr; 61(17):1767-76. PubMed ID: 23500245
[TBL] [Abstract][Full Text] [Related]
4. Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Brooks MM; Chaitman BR; Nesto RW; Hardison RM; Feit F; Gersh BJ; Krone RJ; Sako EY; Rogers WJ; Garber AJ; King SB; Davidson CJ; Ikeno F; Frye RL;
Circulation; 2012 Oct; 126(17):2115-24. PubMed ID: 23008442
[TBL] [Abstract][Full Text] [Related]
5. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction.
Chaitman BR; Hardison RM; Adler D; Gebhart S; Grogan M; Ocampo S; Sopko G; Ramires JA; Schneider D; Frye RL;
Circulation; 2009 Dec; 120(25):2529-40. PubMed ID: 19920001
[TBL] [Abstract][Full Text] [Related]
6. Risk factor control for coronary artery disease secondary prevention in large randomized trials.
Farkouh ME; Boden WE; Bittner V; Muratov V; Hartigan P; Ogdie M; Bertolet M; Mathewkutty S; Teo K; Maron DJ; Sethi SS; Domanski M; Frye RL; Fuster V
J Am Coll Cardiol; 2013 Apr; 61(15):1607-15. PubMed ID: 23500281
[TBL] [Abstract][Full Text] [Related]
7. Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.
Rezende PC; Hueb W; Garzillo CL; Lima EG; Hueb AC; Ramires JA; Kalil Filho R
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1105-12. PubMed ID: 22944095
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of the BARI 2D and COURAGE trials of coronary artery disease.
Kuller LH
Coron Artery Dis; 2010 Nov; 21(7):391-6. PubMed ID: 20634693
[TBL] [Abstract][Full Text] [Related]
9. Coronary artery bypass graft surgery (CABG) for patients with diabetes and multivessel coronary artery disease: identifying patients who would benefit with CABG and understanding the potential mechanisms involved.
Greason KL; Schaff HV
Coron Artery Dis; 2010 Nov; 21(7):402-6. PubMed ID: 20706113
[TBL] [Abstract][Full Text] [Related]
10. Strategies in stable ischemic heart disease: lessons from the COURAGE and BARI-2D trials.
Fernandez SF; Boden WE
Curr Atheroscler Rep; 2010 Nov; 12(6):423-31. PubMed ID: 20845088
[TBL] [Abstract][Full Text] [Related]
11. Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.
Mancini GBJ; Boden WE; Brooks MM; Vlachos H; Chaitman BR; Frye R; Bittner V; Hartigan PM; Dagenais GR
Atherosclerosis; 2018 Oct; 277():186-194. PubMed ID: 29861270
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous coronary intervention versus coronary bypass surgery in United States veterans with diabetes.
Kamalesh M; Sharp TG; Tang XC; Shunk K; Ward HB; Walsh J; King S; Colling C; Moritz T; Stroupe K; Reda D;
J Am Coll Cardiol; 2013 Feb; 61(8):808-16. PubMed ID: 23428214
[TBL] [Abstract][Full Text] [Related]
13. Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Bach RG; Brooks MM; Lombardero M; Genuth S; Donner TW; Garber A; Kennedy L; Monrad ES; Pop-Busui R; Kelsey SF; Frye RL;
Circulation; 2013 Aug; 128(8):785-94. PubMed ID: 23857320
[TBL] [Abstract][Full Text] [Related]
14. Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial.
Sobel BE
Coron Artery Dis; 2010 May; 21(3):189-98. PubMed ID: 20308880
[TBL] [Abstract][Full Text] [Related]
15. Baseline coronary angiographic findings in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D).
Schwartz L; Kip KE; Alderman E; Lu J; Bates ER; Srinivas V; Bach RG; Mighton LD; Feit F; King S; Frye RL;
Am J Cardiol; 2009 Mar; 103(5):632-8. PubMed ID: 19231325
[TBL] [Abstract][Full Text] [Related]
16. Effect of prompt revascularization on outcomes in diabetic patients with stable ischemic heart disease and previous myocardial infarction in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Chung MJ; Novak E; Brown DL
Coron Artery Dis; 2017 Jun; 28(4):301-306. PubMed ID: 28346285
[TBL] [Abstract][Full Text] [Related]
17. Factors related to the selection of surgical versus percutaneous revascularization in diabetic patients with multivessel coronary artery disease in the BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes) trial.
Kim LJ; King SB; Kent K; Brooks MM; Kip KE; Abbott JD; Jacobs AK; Rihal C; Hueb WA; Alderman E; Sing IR; Attubato MJ; Feit F;
JACC Cardiovasc Interv; 2009 May; 2(5):384-92. PubMed ID: 19463459
[TBL] [Abstract][Full Text] [Related]
18. Analysis on outcome of 5284 patients with coronary artery disease: the role of integrative medicine.
Gao ZY; Xu H; Shi DZ; Wen C; Liu BY
J Ethnopharmacol; 2012 Jun; 141(2):578-83. PubMed ID: 21924336
[TBL] [Abstract][Full Text] [Related]
19. Interpreting the results of the COURAGE trial: a non-interventionalist perspective.
Boden WE
Rev Cardiovasc Med; 2009; 10 Suppl 2():S34-44. PubMed ID: 19898280
[TBL] [Abstract][Full Text] [Related]
20. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction.
Farzaneh-Far A; Phillips HR; Shaw LK; Starr AZ; Fiuzat M; O'Connor CM; Sastry A; Shaw LJ; Borges-Neto S
JACC Cardiovasc Imaging; 2012 Jul; 5(7):715-24. PubMed ID: 22789940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
